{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T10:22:31Z","timestamp":1792750951607,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":58,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Chemistry"],"DOI":"10.1186\/s13065-026-01835-9","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T14:06:03Z","timestamp":1779717963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Simultaneous quantification of donepezil and memantine by HPLC\u2013refractive index detection for novel drug delivery systems"],"prefix":"10.1186","volume":"20","author":[{"given":"Baljinder","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souha H.","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. H. M. Musleh","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunmei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"1835_CR1","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jconrel.2024.01.047","volume":"367","author":"B Singh","year":"2024","unstructured":"Singh B, et al. Alzheimer\u2019s disease current therapies, novel drug delivery systems and future directions for better disease management. J Controlled Release. 2024;367:402\u201324.","journal-title":"J Controlled Release"},{"issue":"5","key":"1835_CR2","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1159\/000122962","volume":"25","author":"MR Farlow","year":"2008","unstructured":"Farlow MR, Miller ML, Pejovic V. Treatment options in Alzheimer\u2019s disease: maximizing benefit, managing expectations. Dement Geriatr Cogn Disord. 2008;25(5):408\u201322.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"3","key":"1835_CR3","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/joim.12191","volume":"275","author":"LS Schneider","year":"2014","unstructured":"Schneider LS, et al. Clinical trials and late-stage drug development for A lzheimer\u2019s disease: an appraisal from 1984 to 2014. J Intern Med. 2014;275(3):251\u201383.","journal-title":"J Intern Med"},{"issue":"1","key":"1835_CR4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s43856-024-00527-6","volume":"4","author":"E Yaghmaei","year":"2024","unstructured":"Yaghmaei E, et al. Combined use of Donepezil and Memantine increases the probability of five-year survival of Alzheimer\u2019s disease patients. Commun Med. 2024;4(1):99.","journal-title":"Commun Med"},{"issue":"11","key":"1835_CR5","doi-asserted-by":"publisher","first-page":"e01831","DOI":"10.1002\/brb3.1831","volume":"10","author":"J Guo","year":"2020","unstructured":"Guo J, et al. Memantine, donepezil, or combination therapy\u2014What is the best therapy for Alzheimer\u2019s disease? A network meta-analysis. Brain Behav. 2020;10(11):e01831.","journal-title":"Brain Behav"},{"issue":"2","key":"1835_CR6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s13346-021-00940-7","volume":"11","author":"LC Fonseca","year":"2021","unstructured":"Fonseca LC, et al. Intranasal drug delivery for treatment of Alzheimer\u2019s disease. Drug delivery translational Res. 2021;11(2):411\u201325.","journal-title":"Drug delivery translational Res"},{"issue":"2","key":"1835_CR7","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/jps.22314","volume":"100","author":"H-J Cho","year":"2011","unstructured":"Cho H-J, et al. Poloxamer\/cyclodextrin\/chitosan-based thermoreversible gel for intranasal delivery of fexofenadine hydrochloride. J Pharm Sci. 2011;100(2):681\u201391.","journal-title":"J Pharm Sci"},{"issue":"1","key":"1835_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1211\/0022357011775145","volume":"53","author":"MI Ugwoke","year":"2001","unstructured":"Ugwoke MI, Verbeke N, Kinget R. The biopharmaceutical aspects of nasal mucoadhesive drug delivery. J Pharm Pharmacol. 2001;53(1):3\u201322.","journal-title":"J Pharm Pharmacol"},{"issue":"14","key":"1835_CR9","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1056\/NEJMoa013128","volume":"348","author":"B Reisberg","year":"2003","unstructured":"Reisberg B, et al. Memantine in moderate-to-severe Alzheimer\u2019s disease. N Engl J Med. 2003;348(14):1333\u201341.","journal-title":"N Engl J Med"},{"issue":"9\u201312","key":"1835_CR10","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1080\/10826076.2010.484356","volume":"33","author":"M Swartz","year":"2010","unstructured":"Swartz M. HPLC detectors: a brief review. J Liq Chromatogr Relat Technol. 2010;33(9\u201312):1130\u201350.","journal-title":"J Liq Chromatogr Relat Technol"},{"issue":"6","key":"1835_CR11","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1093\/chromsci\/bmx013","volume":"55","author":"TB Sawant","year":"2017","unstructured":"Sawant TB, et al. The development and validation of novel, simple high-performance liquid chromatographic method with refractive index detector for quantification of memantine hydrochloride in dissolution samples. J Chromatogr Sci. 2017;55(6):603\u20139.","journal-title":"J Chromatogr Sci"},{"issue":"5","key":"1835_CR12","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s40005-015-0184-1","volume":"45","author":"H-J Maeng","year":"2015","unstructured":"Maeng H-J, et al. Validation and application of a simple reverse phase HPLC method for in vitro dissolution studies of memantine hydrochloride tablet. J Pharm Invest. 2015;45(5):415\u201321.","journal-title":"J Pharm Invest"},{"issue":"4","key":"1835_CR13","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1527-3458.2001.tb00204.x","volume":"7","author":"M Shigeta","year":"2001","unstructured":"Shigeta M, Homma A. Donepezil for Alzheimer\u2019s disease: pharmacodynamic, pharmacokinetic, and clinical profiles. CNS Drug Rev. 2001;7(4):353\u201368.","journal-title":"CNS Drug Rev"},{"issue":"1","key":"1835_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.2174\/2468187309666190923111541","volume":"10","author":"M Yasir","year":"2020","unstructured":"Yasir M, et al. Donepezil Base: Physicochemical Characterization, HPLC Method Development, Validation and its Application for the Determination of Shelf Life in Developed Solid Lipid Nanoparticles. Curr Nanomed (Formerly: Recent Pat Nanomedicine). 2020;10(1):48\u201362.","journal-title":"Curr Nanomed (Formerly: Recent Pat Nanomedicine)"},{"key":"1835_CR15","unstructured":"Drugbank. Memantine. [cited 2025 20 May]."},{"key":"1835_CR16","unstructured":"Drugbank. Donepzil. [cited 2025 20 May]; Available from: https:\/\/go.drugbank.com\/drugs\/DB00843"},{"issue":"1","key":"1835_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3390\/pharmaceutics14010205","volume":"14","author":"L Dinh","year":"2022","unstructured":"Dinh L, et al. Formulation, preparation, characterization, and evaluation of dicarboxylic ionic liquid donepezil transdermal patches. Pharmaceutics. 2022;14(1):205.","journal-title":"Pharmaceutics"},{"issue":"1","key":"1835_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13065-024-01377-y","volume":"19","author":"MM Abd Elwahab","year":"2025","unstructured":"Abd Elwahab MM, et al. Assessment of greenness, blueness, and whiteness profiles of a validated HPLC-DAD method for quantitation of Donepezil HCl and Curcumin in their laboratory prepared co-formulated nanoliposomes. BMC Chem. 2025;19(1):17.","journal-title":"BMC Chem"},{"issue":"9","key":"1835_CR19","doi-asserted-by":"publisher","first-page":"e0309802","DOI":"10.1371\/journal.pone.0309802","volume":"19","author":"YB Shin","year":"2024","unstructured":"Shin YB, et al. Optimized method development and validation for determining donepezil in rat plasma: A liquid-liquid extraction, LC-MS\/MS, and design of experiments approach. PLoS ONE. 2024;19(9):e0309802.","journal-title":"PLoS ONE"},{"key":"1835_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jchromb.2015.07.042","volume":"1001","author":"M Bhateria","year":"2015","unstructured":"Bhateria M, et al. Development of an LC\u2013MS\/MS method for simultaneous determination of memantine and donepezil in rat plasma and its application to pharmacokinetic study. J Chromatogr B. 2015;1001:131\u20139.","journal-title":"J Chromatogr B"},{"issue":"9","key":"1835_CR21","doi-asserted-by":"publisher","first-page":"4714","DOI":"10.1021\/acs.molpharmaceut.3c00454","volume":"20","author":"M Handa","year":"2023","unstructured":"Handa M, et al. Simultaneous Intranasal Codelivery of Donepezil and Memantine in a Nanocolloidal Carrier: Optimization, Pharmacokinetics, and Pharmacodynamics Studies. Mol Pharm. 2023;20(9):4714\u201328.","journal-title":"Mol Pharm"},{"issue":"9","key":"1835_CR22","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1007\/s13738-025-03263-3","volume":"22","author":"T Khan","year":"2025","unstructured":"Khan T, et al. Green and sensitive stability-indicating spectrofluorimetric assay method for the determination of donepezil HCl in pure and tablet dosage form and its kinetic application. J Iran Chem Soc. 2025;22(9):1863\u201378.","journal-title":"J Iran Chem Soc"},{"key":"1835_CR23","doi-asserted-by":"publisher","first-page":"ACI","DOI":"10.4137\/ACI.S3936","volume":"5","author":"B Narola","year":"2010","unstructured":"Narola B, et al. A validated stability-indicating reverse phase HPLC assay method for the determination of memantine hydrochloride drug substance with UV-detection using precolumn derivatization technique. Anal Chem Insights. 2010;5:ACI.","journal-title":"Anal Chem Insights"},{"issue":"2","key":"1835_CR24","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3797\/scipharm.1310-09","volume":"82","author":"H Jalalizadeh","year":"2013","unstructured":"Jalalizadeh H, et al. A stability-indicating HPLC method for the determination of memantine hydrochloride in dosage forms through derivatization with 1-fluoro-2, 4-dinitrobenzene. Sci Pharm. 2013;82(2):265.","journal-title":"Sci Pharm"},{"issue":"10","key":"1835_CR25","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1134\/S1061934824700813","volume":"79","author":"H Varu","year":"2024","unstructured":"Varu H, et al. Kinetic Spectrophotometric Determination of Memantine Hydrochloride Based on the Formation of Its Dinitrochlorobenzene Adduct. J Anal Chem. 2024;79(10):1431\u20138.","journal-title":"J Anal Chem"},{"issue":"6","key":"1835_CR26","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1097\/FTD.0b013e31826933ab","volume":"34","author":"E Haen","year":"2012","unstructured":"Haen E, et al. Implementation of a cost-effective HPLC\/UV approach for routine medical quantification of memantine in human serum. Ther Drug Monit. 2012;34(6):702\u201312.","journal-title":"Ther Drug Monit"},{"issue":"1","key":"1835_CR27","doi-asserted-by":"publisher","first-page":"502652","DOI":"10.1155\/2013\/502652","volume":"2013","author":"S del Rio-Sancho","year":"2013","unstructured":"del Rio-Sancho S, et al. High-Performance Liquid Chromatographic Ultraviolet Determination of Memantine Hydrochloride after In Vitro Transdermal Diffusion Studies. J Chem. 2013;2013(1):502652.","journal-title":"J Chem"},{"issue":"9","key":"1835_CR28","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.3390\/ph17091162","volume":"17","author":"D Nunes","year":"2024","unstructured":"Nunes D, et al. Development and Validation of a Simple UV\u2013HPLC Method to Quantify the Memantine Drug Used in Alzheimer\u2019s Treatment. Pharmaceuticals. 2024;17(9):1162.","journal-title":"Pharmaceuticals"},{"key":"1835_CR29","unstructured":"Guidance R. Validation of chromatographic methods. Center for Drug Evaluation and Research (CDER), Washington, 1994. 2."},{"issue":"1","key":"1835_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4103\/2229-5186.79345","volume":"2","author":"A Shrivastava","year":"2011","unstructured":"Shrivastava A, Gupta VB. Methods for the determination of limit of detection and limit of quantitation of the analytical methods. Chron Young Sci. 2011;2(1):21\u20135.","journal-title":"Chron Young Sci"},{"issue":"19","key":"1835_CR31","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.3390\/polym13193376","volume":"13","author":"KH Ullah","year":"2021","unstructured":"Ullah KH, et al. Poloxamer 407 based gel formulations for transungual delivery of hydrophobic drugs: Selection and optimization of potential additives. Polymers. 2021;13(19):3376.","journal-title":"Polymers"},{"key":"1835_CR32","doi-asserted-by":"publisher","first-page":"103631","DOI":"10.1016\/j.jddst.2022.103631","volume":"75","author":"M Yasir","year":"2022","unstructured":"Yasir M, et al. Nose to brain delivery of donepezil through surface modified NLCs: Formulation development, optimization, and brain targeting study. J Drug Deliv Sci Technol. 2022;75:103631.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1","key":"1835_CR33","doi-asserted-by":"publisher","first-page":"2606450","DOI":"10.1080\/16583655.2025.2606450","volume":"20","author":"AH Akabari","year":"2026","unstructured":"Akabari AH, et al. White analytical chemistry\u2013aligned eco-friendly, stability-indicating HPLC and HPTLC methods for simultaneous estimation of efonidipine hydrochloride ethanolate and chlorthalidone. J Taibah Univ Sci. 2026;20(1):2606450.","journal-title":"J Taibah Univ Sci"},{"issue":"1","key":"1835_CR34","doi-asserted-by":"publisher","first-page":"54","DOI":"10.2174\/0118723128346156250217055422","volume":"18","author":"VA Rabadiya","year":"2025","unstructured":"Rabadiya VA, Shah N, Akabari AH, Novel Stability-Indicating A. HPLC Method with Kinetics Study for the Concurrent Analysis of Anti-Hypertensive Drug Combination of Atenolol and Indapamide. Drug Metabolism Bioanalysis Lett. 2025;18(1):54\u201370.","journal-title":"Drug Metabolism Bioanalysis Lett"},{"key":"1835_CR35","doi-asserted-by":"crossref","unstructured":"Akabari AH. Development and validation of a novel simultaneous equation and Q-absorbance ratio method for the quantitative estimation of atenolol and hydrochlorothiazide in combined tablet dosage forms: A green analytical chemistry approach. Elsevier; 2025.","DOI":"10.1016\/j.greeac.2025.100224"},{"issue":"4","key":"1835_CR36","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1039\/c0gc00918k","volume":"13","author":"RK Henderson","year":"2011","unstructured":"Henderson RK, et al. Expanding GSK\u2019s solvent selection guide\u2013embedding sustainability into solvent selection starting at medicinal chemistry. Green Chem. 2011;13(4):854\u201362.","journal-title":"Green Chem"},{"issue":"3","key":"1835_CR37","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1039\/D0AY02169E","volume":"13","author":"M Gamal","year":"2021","unstructured":"Gamal M, et al. Comparative study of four greenness assessment tools for selection of greenest analytical method for assay of hyoscine N-butyl bromide. Anal Methods. 2021;13(3):369\u201380.","journal-title":"Anal Methods"},{"issue":"1","key":"1835_CR38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13065-025-01410-8","volume":"19","author":"DD Nakmode","year":"2025","unstructured":"Nakmode DD, et al. Analytical method for simultaneous quantification of levodopa and carbidopa in the injectable oleogel formulation by HPLC. BMC Chem. 2025;19(1):43.","journal-title":"BMC Chem"},{"issue":"14","key":"1835_CR39","doi-asserted-by":"publisher","first-page":"10076","DOI":"10.1021\/acs.analchem.0c01887","volume":"92","author":"F Pena-Pereira","year":"2020","unstructured":"Pena-Pereira F, Wojnowski W, Tobiszewski M. AGREE\u2014Analytical GREEnness Metric Approach and Software. Anal Chem. 2020;92(14):10076\u201382.","journal-title":"Anal Chem"},{"issue":"19","key":"1835_CR40","doi-asserted-by":"publisher","first-page":"7598","DOI":"10.1039\/D3GC02347H","volume":"25","author":"N Manousi","year":"2023","unstructured":"Manousi N, et al. Blue applicability grade index (BAGI) and software: a new tool for the evaluation of method practicality. Green Chem. 2023;25(19):7598\u2013604.","journal-title":"Green Chem"}],"container-title":["BMC Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13065-026-01835-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-026-01835-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-026-01835-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T22:34:10Z","timestamp":1784673250000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13065-026-01835-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1835"],"URL":"https:\/\/doi.org\/10.1186\/s13065-026-01835-9","relation":{},"ISSN":["2661-801X"],"issn-type":[{"value":"2661-801X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"20 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"161"}}